A series of mouse studies commissioned by the Defence R&D Canada --Suffield, whose goal is to protect Canadian military forces against chemical and biological warfare, recorded survival rates from lethal exposure to anthrax in excess of 80% using systemic (injected) beta glucan, compared with survival rates of only 20-50% in untreated animals. In addition, analysis of the anthrax remaining in the lungs of the survival animals showed that more than 90% of the beta glucan-treated animals were bacteria-free, meaning the animals were cured 11 days after infection.
The most amazing thing about Beta glucan is it not a treatment for any disease or condition. Beta Glucan is an immunomodulator that has been shown to support immune system function.

Subsequent mouse-anthrax research demonstrated that both prophylactic and therapeutic oral administration of the immunomodulator Beta 1, 3-D Glucan significantly increased the survival rate of infected mice. In animals, prophylactically administered oral Beta 1, 3-D Glucan increased survival from 50% in control animals to 100% in treated animals (Figure 1). In animals, therapeutically administered oral Beta 1, 3-D Glucan increased survival from 30% in control-infected animals up to 90% in immunomodulator treated animals (Figure 2).